Unique French Biotech with two approved drugs for commercialization in the United States by partners and a broad pipeline of drug candidates in development. Nicox is an international ophthalmic company developing innovative solutions to help maintain vision and improve ocular health.
Nicox: presentation and achievements
Indications and markets targeted by Nicox
Interview with OIS-TV (Ophthalmology Innovation Summit) on May 11, 2018
WebTV interview La Bourse et La Vie on June 27, 2018 – in French
Stay informed
Get news on Nicox
Download Nicox’s factsheet (in French only)